Thiophene derivatives as antiviral agents for flavivirus infection

Details for Australian Patent Application No. 2002344854 (hide)

Owner Virochem Pharma Inc.

Inventors Pereira, Oswy Z.; Wang, Wuyi; Das, Sanjoy Kumar; Bedard, Jean; Nguyen Ba, Nghe; Reddy, Thumkunta Jagadeeswar; Siddiqui, M. Arshad; Yannopoulos, Constantin; Chan, Chun Kong Laval

Agent Griffith Hack

Pub. Number AU-B-2002344854

PCT Number PCT/CA02/00876

PCT Pub. Number WO2002/100851

Priority 60/296,731 11.06.01 US

Filing date 11 June 2002

Wipo publication date 23 December 2002

Acceptance publication date 6 November 2008

International Classifications

C07D 333/40 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/20 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/382 (2006.01) - having six-membered rings, e.g. thioxanthenes

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/4035 (2006.01)

A61K 31/404 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/42 (2006.01) - Oxazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/437 (2006.01)

A61K 31/4436 (2006.01)

A61K 31/4535 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4725 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

6 March 2003 Complete Application Filed

  Priority application(s): 60/296,731 11.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002344854

20 January 2005 Assignment before Grant

  Shire Biochem Inc. The application has been assigned to Virochem Pharma Inc.

6 November 2008 Application Accepted

  Published as AU-B-2002344854

5 March 2009 Standard Patent Sealed

2 February 2012 Alteration of Name

  The name of the patentee has been altered to Vertex Pharmaceuticals (Canada) Incorporated 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002344855-COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS

2002344853-NOVEL ABCA10 TRANSPORTER AND USES THEREOF